Piccioni D - Search Results

1

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.

Kato S, Schwaederle M, Daniels GA, Piccioni D, Kesari S, Bazhenova L, Shimabukuro K, Parker BA, Fanta P, Kurzrock R. Kato S, et al. Among authors: piccioni d. Cell Cycle. 2015;14(8):1252-9. doi: 10.1080/15384101.2015.1014149. Cell Cycle. 2015. PMID: 25695927 Free PMC article.

2

Clinical trials of viral therapy for malignant gliomas.

Piccioni DE, Kesari S. Piccioni DE, et al. Expert Rev Anticancer Ther. 2013 Nov;13(11):1297-305. doi: 10.1586/14737140.2013.851160. Epub 2013 Oct 21. Expert Rev Anticancer Ther. 2013. PMID: 24138481 Review.

3

Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases.

Nomura N, Pastorino S, Jiang P, Lambert G, Crawford JR, Gymnopoulos M, Piccioni D, Juarez T, Pingle SC, Makale M, Kesari S. Nomura N, et al. Among authors: piccioni d. Cancer Cell Int. 2014 Mar 20;14(1):26. doi: 10.1186/1475-2867-14-26. Cancer Cell Int. 2014. PMID: 24645697 Free PMC article.

4

Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.

Scott BJ, van Vugt VA, Rush T, Brown T, Chen CC, Carter BS, Schwab R, Fanta P, Helsten T, Bazhenova L, Parker B, Pingle S, Saria MG, Brown BD, Piccioni DE, Kesari S. Scott BJ, et al. Among authors: piccioni de. J Neurooncol. 2014 Sep;119(2):361-8. doi: 10.1007/s11060-014-1486-2. Epub 2014 Jun 19. J Neurooncol. 2014. PMID: 24942463

5

Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas.

van Vugt VA, Piccioni DE, Brown BD, Brown T, Saria MG, Juarez T, Kesari S. van Vugt VA, et al. Among authors: piccioni de. CNS Oncol. 2014 Jul;3(4):257-65. doi: 10.2217/cns.14.29. CNS Oncol. 2014. PMID: 25286037 Free PMC article.

6

Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.

Fogal V, Babic I, Chao Y, Pastorino S, Mukthavaram R, Jiang P, Cho YJ, Pingle SC, Crawford JR, Piccioni DE, Kesari S. Fogal V, et al. Oncotarget. 2015 Jan 20;6(2):1157-70. doi: 10.18632/oncotarget.2708. Oncotarget. 2015. PMID: 25528767 Free PMC article.

7

Cyclin alterations in diverse cancers: Outcome and co-amplification network.

Schwaederlé M, Daniels GA, Piccioni DE, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R. Schwaederlé M, et al. Oncotarget. 2015 Feb 20;6(5):3033-42. doi: 10.18632/oncotarget.2848. Oncotarget. 2015. PMID: 25596748 Free PMC article.

8

Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.

Nozawa A, Rivandi AH, Kanematsu M, Hoshi H, Piccioni D, Kesari S, Hoh CK. Nozawa A, et al. Among authors: piccioni d. Nucl Med Commun. 2015 Jun;36(6):573-81. doi: 10.1097/MNM.0000000000000288. Nucl Med Commun. 2015. PMID: 25714806 Free PMC article.

9

On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients.

Schwaederle M, Daniels GA, Piccioni DE, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R. Schwaederle M, et al. Mol Cancer Ther. 2015 Jun;14(6):1488-94. doi: 10.1158/1535-7163.MCT-14-1061. Epub 2015 Apr 7. Mol Cancer Ther. 2015. PMID: 25852059

10

Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer.

Schwaederle M, Daniels GA, Piccioni DE, Kesari S, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R. Schwaederle M, et al. Cell Cycle. 2015;14(11):1730-7. doi: 10.1080/15384101.2015.1033596. Cell Cycle. 2015. PMID: 25928476 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page